These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 28457560)

  • 1. Three-year follow-up of patients with acetylcholine-induced coronary artery spasm combined with insignificant coronary stenosis.
    Choi BG; Park SH; Rha SW; Ahn J; Choi SY; Byun JK; Li H; Mashaly A; Shim MS; Kang JH; Kim W; Choi JY; Park EJ; Lee S; Na JO; Choi CU; Lim HE; Kim EJ; Park CG; Seo HS; Oh DJ
    Int J Cardiol; 2017 Jul; 238():66-71. PubMed ID: 28457560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of alcohol drinking on acetylcholine-induced coronary artery spasm in Korean populations.
    Sohn SM; Choi BG; Choi SY; Byun JK; Mashaly A; Park Y; Jang WY; Kim W; Choi JY; Park EJ; Na JO; Choi CU; Lim HE; Kim EJ; Park CG; Seo HS; Oh DJ; Rha SW
    Atherosclerosis; 2018 Jan; 268():163-169. PubMed ID: 29227870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of myocardial bridge on coronary artery spasm and long-term clinical outcomes in patients without significant atherosclerotic stenosis.
    Nam P; Choi BG; Choi SY; Byun JK; Mashaly A; Park Y; Jang WY; Kim W; Choi JY; Park EJ; Na JO; Choi CU; Lim HE; Kim EJ; Park CG; Seo HS; Oh DJ; Rha SW
    Atherosclerosis; 2018 Mar; 270():8-12. PubMed ID: 29407892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five-year major clinical outcomes according to severity of coronary artery spasm as assessed by intracoronary acetylcholine provocation test.
    Kim YH; Her AY; Rha SW; Choi BG; Shim M; Choi SY; Byun JK; Li H; Kim W; Kang JH; Choi JY; Park EJ; Park SH; Lee S; Na JO; Choi CU; Lim HE; Kim EJ; Park CG; Seo HS; Oh DJ
    Arch Cardiovasc Dis; 2018 Mar; 111(3):144-154. PubMed ID: 29030064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five-year clinical outcomes in patients with significant coronary artery spasm: A propensity score-matched analysis.
    Choi BG; Park SH; Rha SW; Park JY; Choi SY; Park Y; Xu S; Ngow HA; Ali J; Li H; Kim JB; Lee S; Na JO; Choi CU; Lim HE; Kim JW; Kim EJ; Park CG; Seo HS; Oh DJ
    Int J Cardiol; 2015 Apr; 184():533-539. PubMed ID: 25767010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Renin-Angiotensin System Inhibitors on Long-Term Clinical Outcomes of Patients With Coronary Artery Spasm.
    Choi BG; Jeon SY; Rha SW; Park SH; Shim MS; Choi SY; Byun JK; Li H; Choi JY; Park EJ; Park SH; Lee JJ; Lee S; Na JO; Choi CU; Lim HE; Kim JW; Kim EJ; Park CG; Seo HS; Oh DJ
    J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27444508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of vasomotion type on prognosis of coronary artery spasm induced by acetylcholine provocation test of left coronary artery.
    Lee EM; Choi MH; Seo HS; Kim HK; Kim NH; Choi CU; Kim JW; Lim HE; Kim EJ; Rha SW; Park CG; Oh DJ
    Atherosclerosis; 2017 Feb; 257():195-200. PubMed ID: 28012648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Diltiazem Alone versus Diltiazem with Nitrate on Five-Year Clinical Outcomes in Patients with Significant Coronary Artery Spasm.
    Park T; Park JY; Rha SW; Seo HS; Choi BG; Choi SY; Byun JK; Park SH; Park EJ; Choi JY; Park SH; Lee JJ; Lee S; Na JO; Choi CU; Lim HE; Kim JW; Kim EJ; Park CG; Oh DJ
    Yonsei Med J; 2017 Jan; 58(1):90-98. PubMed ID: 27873500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of drug-eluting stent-associated coronary artery spasm on 3-year clinical outcomes: A propensity score matching analysis.
    Ali J; Rha SW; Choi BG; Byun JK; Choi SY; Cha JA; Park S; Lee K; Back S; Lee J; Kang DO; Choi JY; Roh SY; Na JO; Choi CU; Kim JW; Kim EJ; Park CG; Seo HS; Wasim M; Hassan Z
    Indian Heart J; 2022; 74(3):182-186. PubMed ID: 35576993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of coronary artery spasm on long-term outcomes in survivors of acute myocardial infarction.
    Deyama J; Nakamura T; Saito Y; Obata JE; Fujioka D; Nakamura K; Watanabe K; Kugiyama K
    Int J Cardiol; 2018 Apr; 257():7-11. PubMed ID: 29506741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex Difference in Coronary Artery Spasm Tested by Intracoronary Acetylcholine Provocation Test in Patients with Nonobstructive Coronary Artery Disease.
    Park JY; Choi SY; Rha SW; Choi BG; Noh YK; Kim YH
    J Interv Cardiol; 2022; 2022():5289776. PubMed ID: 36131847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes mellitus is not a risk factor for coronary artery spasm as assessed by an intracoronary acetylcholine provocation test: angiographic and clinical characteristics of 986 patients.
    Li YJ; Hyun MH; Rha SW; Chen KY; Jin Z; Dang Q; Park CM; Lee JE; Park JY; Choi CU; Na JO; Lim HE; Kim JW; Kim EJ; Park CG; Seo HS; Oh DJ
    J Invasive Cardiol; 2014 Jun; 26(6):234-9. PubMed ID: 24907077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of omitting provocation test with 50 μg of acetylcholine in left coronary artery.
    Saito Y; Kitahara H; Shoji T; Tokimasa S; Nakayama T; Sugimoto K; Fujimoto Y; Kobayashi Y
    Heart Vessels; 2017 Jun; 32(6):685-689. PubMed ID: 27873006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiographic and clinical characteristics of patients with acetylcholine-induced coronary vasospasm on follow-up coronary angiography following drug-eluting stent implantation.
    Ito S; Nakasuka K; Morimoto K; Inomata M; Yoshida T; Tamai N; Suzuki S; Murakami Y; Morino A; Shimizu Y; Sato K
    J Invasive Cardiol; 2011 Feb; 23(2):57-64. PubMed ID: 21297201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of coronary artery spasm by two pharmacological agents: comparison between intracoronary injection of acetylcholine and ergonovine.
    Sueda S; Kohno H; Fukuda H; Ochi N; Kawada H; Hayashi Y; Uraoka T
    Coron Artery Dis; 2003 Sep; 14(6):451-7. PubMed ID: 12966266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcome according to spasm type of single coronary artery provoked by intracoronary ergonovine tests in patients without significant organic stenosis.
    Kim DW; Her SH; Ahn Y; Shin DI; Han SH; Kim DS; Choi DJ; Kwon HM; Gwon HC; Jo SH; Rha SW; Baek SH
    Int J Cardiol; 2018 Feb; 252():6-12. PubMed ID: 29249438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Trimetazidine Treatment on 5-year Clinical Outcomes in Patients with Significant Coronary Artery Spasm: A Propensity Score Matching Study.
    Kim YH; Her AY; Rha SW; Choi BG; Choi SY; Byun JK; Mashaly A; Park Y; Jang WY; Kim W; Choi JY; Park EJ; Na JO; Choi CU; Lim HE; Kim EJ; Park CG; Seo HS; Oh DJ
    Am J Cardiovasc Drugs; 2018 Apr; 18(2):117-127. PubMed ID: 29143297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetylcholine-Provoked Coronary Spasm at Site of Significant Organic Stenosis Predicts Poor Prognosis in Patients With Coronary Vasospastic Angina.
    Ishii M; Kaikita K; Sato K; Tanaka T; Sugamura K; Sakamoto K; Izumiya Y; Yamamoto E; Tsujita K; Yamamuro M; Kojima S; Soejima H; Hokimoto S; Matsui K; Ogawa H
    J Am Coll Cardiol; 2015 Sep; 66(10):1105-15. PubMed ID: 26337988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical impact of selective spasm provocation tests: comparisons between acetylcholine and ergonovine in 1508 examinations.
    Sueda S; Kohno H; Fukuda H; Ochi N; Kawada H; Hayashi Y; Uraoka T
    Coron Artery Dis; 2004 Dec; 15(8):491-7. PubMed ID: 15585990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maximal acetylcholine dose of 200 μg into the left coronary artery as a spasm provocation test: comparison with 100 μg of acetylcholine.
    Sueda S; Kohno H; Miyoshi T; Sakaue T; Sasaki Y; Habara H
    Heart Vessels; 2015 Nov; 30(6):771-8. PubMed ID: 25179297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.